StreetAlpha.app
Home › Stocks › LLY

ELI LILLY & Co (LLY)

Healthcare
$1347.11
▼ −0.30%
LAST CLOSE · NOV 20

Eli Lilly is a pharmaceutical company that develops and sells medicines for diabetes, obesity, cancer, and other conditions. It last closed at $1347.11 on Nov 20, down 0.30% on the day. The next earnings report for LLY is expected around Wed, Feb 3, 2027. For the quarter ended Sep 2026, LLY reported EPS of $7.22 on revenue of $24.40B, with revenue up 38.6% from a year ago. Over its last 8 reports the stock moved an average of 8.5% the session after earnings. Over the last 12 months LLY insiders bought $0 of stock on the open market and sold $853.6M, according to SEC Form 4 filings.

AI Auto Pilots
Is LLY in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LLY.

Key Stats

Last 12 months
Results
Revenue
$86.5B
+45.5% vs a year ago
Net income
$27.6B
+49.8% vs a year ago
EPS (diluted)
$30.81
+50.7% vs a year ago
Gross margin
83.6%
$72.3B gross profit
Valuation
Market cap
$1.27T
940.7M shares
P/E
43.7
Price over 12 month EPS
Price to sales
14.7
Market cap over revenue
Dividend yield
0.50%
$6.69 a share over 12 months
Balance sheet
Cash & equivalents
$4.9B
At Sep 30
Debt
$49.5B
At Sep 30
Shareholder equity
$40.3B
Buybacks
$5.8B
Last 12 months
CEODavid A. Ricks
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $28.3B$28.3BFY2021FY2022: $28.5B$28.5BFY2022FY2023: $34.1B$34.1BFY2023FY2024: $45.0B$45.0BFY2024FY2025: $65.2B$65.2BFY2025

From LLY's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Feb 3
Estimated date · Time not announced
Reported EPS
$7.22
Quarter ended Sep 2026
Year ago EPS
$6.21
+16.3% on a GAAP basis
Revenue
$24.40B
+38.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $4.88Dec '24Mar 2025: $3.06Mar '25Jun 2025: $6.29Jun '25Sep 2025: $6.21Sep '25Dec 2025: $7.39Dec '25Mar 2026: $8.26Mar '26Jun 2026: $7.94Jun '26Sep 2026: $7.22Sep '26Latest $7.22
Revenue by quarter
Dec 2024: $13.53BDec '24Mar 2025: $12.73BMar '25Jun 2025: $15.56BJun '25Sep 2025: $17.60BSep '25Dec 2025: $19.29BDec '25Mar 2026: $19.80BMar '26Jun 2026: $22.97BJun '26Sep 2026: $24.40BSep '26Latest $24.40B
How LLY moved after its last 8 reports
Average move the session after a report ±8.5%
Oct 29, 2026Time not announced+6.6%
Aug 5, 2026Time not announced+4.9%
Apr 30, 2026Time not announced+9.8%
Feb 4, 2026Time not announced+10.3%
Oct 30, 2025Time not announced+3.8%
Aug 7, 2025Time not announced−14.1%
May 1, 2025Time not announced−11.7%
Jan 14, 2025Time not announced−6.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on LLYStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on LLY
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on LLY

Technical Analysis

LLY · as of the Nov 20 close · updated each morning
Uptrend

The stock sits between its 20 and 50 day averages. It is 17% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 49). The nearest support is the Pivot S1 at $1335.23, and the nearest resistance the Pivot at $1353.64.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 3.1%/day
Key levels
$1475.2552 week high+9.5%
$1449.68Swing high (Oct 30)+7.6%
$1383.9120 day average+2.7%
$1365.52Pivot R1+1.4%
$1353.64Pivot+0.5%
$1347.11Last close
$1335.23Pivot S1−0.9%
$1333.22Swing low (Nov 6)−1.0%
$1266.9250 day average−6.0%
$1225.79100 day average−9.0%
$1117.90200 day average−17.0%
$850.5152 week low−36.9%
Indicators
RSI (14)49.50Middle of its rangeNeutral
MACD33.24Below its signal lineBearish
Stochastic19.1Near the bottom of its rangeOversold
ADX (14)32.8Trending up
Williams %R-90.2Oversold below −80, overbought above −20Oversold
CCI (20)-52.5Oversold below −100, overbought above 100Neutral
Rate of change−0.5%Change over 10 sessionsBearish
ATR (14)$42.43Typical daily range, 3.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for LLY

What happened before

See how LLY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow LLY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How LLY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for LLYHow many large options trades hit LLY, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

LLY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲2,338 buying vs 1,720 selling
  • ▼Held by funds -0.9 pts
  • ●Funds holding -17
  • ▲Superinvestors: 4 added, 3 cut
  • ▲Put/call 1.91 to 1.47
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding4,6344,651−0.4%
In funds' top 10450479−6.1%
Held by funds82.9%83.8%−0.9 pts
New / increased163 / 2,175352 / 2,184−7.8%
Reduced / sold out1,576 / 1441,462 / 108+9.6%
Put/call ratio1.471.91−23.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LLY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

LLY Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$853.6M16 sales · 5 insiders
3% of the selling was under pre-arranged trading plans.
2025-12 sold $7.0M2026-01 sold $323.9M2026-05 sold $15.8M2026-06 sold $2.9M2026-08 sold $16.0M2026-11 sold $7.0MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 2Anat HakimEVP, GC & SecretarySale plan5,000$1402.52$7.0M
Aug 17Patrik JonssonEVP & President, LLY Int'lSale plan6,500$1175.10$7.6M
Aug 10Donald A ZakrowskiSVP, Finance, & CAOSale plan2,000$1185.01$2.4M
Aug 7Anat HakimEVP, GC & SecretarySale plan5,000$1190.00$6.0M
Jun 10Ilya YuffaEVP&Pres, LLY USA&Global CapabSale plan2,500$1150.77$2.9M
May 6Lilly Endowment IncFormer 10% ShareholderSale15,828$995.36$15.8M
Every insider buy and sale for LLY over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See LLY insider trades →

From SEC Form 4 filings by LLY's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

LLY Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$5.8B
0.5% yield
Left in program
$6.6B
0.5% of value
Shares outstanding, 12 months
−0.5%
Fewer shares
Last quarter
$373.8M
Sep 2026
Avg price paid, last quarter
$1168.00
320K shares bought
S&P 500 rank by spending
#45 of 358
 
Spent each quarter, last 3 yearsTop bar $2.3B
Dec 2023: $196K, average price $151.51Mar 2024: $0Jun 2024: $0Sep 2024: $521.5M, average price $896.13Dec 2024: $2.2B, average price $534.72Mar 2025: $1.2B, average price $883.24Jun 2025: $692.3M, average price $761.63Sep 2025: $707.6M, average price $699.86Dec 2025: $1.5B, average price $1001.57Mar 2026: $2.3B, average price $987.16Jun 2026: $1.6B, average price $975.65Sep 2026: $373.8M, average price $1168.00
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LLY is in one of them and how their past LLY trades turned out.

LLY in the AI portfolios
Loading…

LLY News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LLY in an article yet. Here's the latest on the wider market.

LLY in the news

LLY Congress Trades

All congress trades →
Trades, 12 months
28
Buys
11
39%
Sells
17
61%
People
12
Last filed Nov 18
Who traded LLY · since 2013
Latest 5 filings of 193
Michael RulliSell (partial)
$1K – $15KTraded Nov 4, 2026Filed Nov 18, 2026
$1K – $15KTraded Nov 3, 2026Filed Nov 12, 2026
$1K – $15KTraded Nov 3, 2026Filed Nov 12, 2026
$1K – $15KTraded Oct 20, 2026Filed Nov 10, 2026
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
Michael RulliR · OHSell (partial)$1K – $15KNov 4, 2026Nov 18, 202614 d
David TaylorR · OHSell$1K – $15KNov 3, 2026Nov 12, 20269 d
David TaylorR · OHSell$1K – $15KNov 3, 2026Nov 12, 20269 d
Gilbert CisnerosD · CABuy$1K – $15KOct 20, 2026Nov 10, 202621 d
Ro KhannaD · CABuy$1K – $15KSep 4, 2026Oct 7, 202633 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About ELI LILLY &

Eli Lilly is a pharmaceutical company based in Indianapolis, Indiana. It discovers, develops, manufactures, and sells human medicines, with major products for diabetes and obesity, as well as treatments for cancer, immune conditions, migraine, and Alzheimer's disease. Its customers include wholesalers, pharmacies, hospitals, insurers, and healthcare providers, and it also sells directly to patients through its LillyDirect platform. Its products are sold in many countries around the world.

Headquarters
Indianapolis, IN
Founded
1875